Dr Damian Krysan

Damian Krysan grew up in the Great Plains state of South Dakota, United States. After receiving a BA in chemistry from Grinnell College, he obtained a PhD in organic chemistry at Northwestern University. Following postdoctoral training at Emory University in the lab of Lanny Liebeskind, he was a chemist at Abbott Labs and was part of the team that brought the HIV protease inhibitor, Ritonivir, to the clinic. He left the pharmaceutical industry in 1996 to attend medical school at the University of Michigan where he also completed a residency in pediatrics and a fellowship in pediatric infectious disease. During that time, he was also a Pediatric Infectious Disease Society research fellow in the laboratory of Robert Fuller where he learned yeast genetics and protease enzymology. In 2005, he moved to a faculty position at the University of Rochester Medical Center and in 2017 to the University of Iowa Carver College of Medicine, where is currently Chief of Pediatric Infectious Disease. His research is focused on three areas: the discovery and pre-clinical development of new antifungal small molecules; genetic analysis of Candida albicans and Cryptococcus neoformans pathogenesis; and the role of pyroptosis in the innate host response to fungal pathogens.